PRP Needle: How It’s Used and What Patients Can Expect

A PRP injection uses a small needle to deliver a concentrated dose of your own platelets directly into damaged tissue, whether that’s an arthritic knee, a torn tendon, or a thinning scalp. The procedure starts with a standard blood draw, runs the sample through a centrifuge to isolate the platelet-rich layer, and then reinjects that concentrate where it’s needed. Most sessions take under an hour from start to finish, and the recovery window is relatively short compared to surgery. But the specifics of the needle itself, the evidence behind different uses, and what you should realistically expect in terms of pain and results are worth understanding before you book an appointment.

How PRP Is Made From Your Blood

PRP stands for platelet-rich plasma, and it comes entirely from your own blood. A clinician draws a small sample, typically in the range of a few tubes’ worth, and places it in a centrifuge. The centrifuge spins the blood at controlled speeds to separate it into layers: red blood cells sink to the bottom, a thin platelet-rich band forms in the middle, and platelet-poor plasma rises to the top. The middle layer is what gets extracted and prepared for injection.¹

The spinning protocol matters more than you might think. Research has shown that a two-step centrifugation process can recover roughly 70 to 80 percent of the platelets in the original blood sample while concentrating them to about five times their normal level, all without damaging their structure or viability.² Different clinics use different commercial kits, and these kits vary in how much platelet concentration they actually achieve. That variation is one reason outcomes can differ from one provider to the next, even for the same condition.

Once isolated, the platelet concentrate is rich in growth factors stored inside tiny compartments called alpha granules. When platelets are activated at the injection site, they release a burst of signaling proteins that promote cell growth, blood vessel formation, and tissue repair. These include factors that attract the cells responsible for building new connective tissue and factors that stimulate new blood vessel growth into injured areas.³ The idea is to deliver a concentrated version of the body’s natural healing signals right where they’re needed.

The Needle Itself and How Injections Are Performed

Patients often worry about the needle, which is understandable. The good news is that research has found very fine needles work well for PRP. One study tested the smallest commercially available gauge needles and found that even 30-gauge needles, the same ultra-thin size used for insulin and cosmetic injections, did not damage platelet quality or function. The researchers recommended 30-gauge needles specifically to minimize injection pain.⁴ In practice, the needle gauge a clinician uses depends on the target tissue. A shallow scalp injection for hair loss can use a very fine needle, while a deeper joint injection into the knee might use a slightly larger one to reach the joint space reliably.

For musculoskeletal injections, ultrasound guidance is increasingly standard. An ultrasound image lets the clinician see the needle in real time and steer it precisely into the damaged area, whether that’s a tendon tear, a joint capsule, or a specific ligament. Accurate placement matters: research has emphasized that the preliminary ultrasound should be done carefully to localize the lesion so the needle can be guided directly into the corresponding site.⁵ Without imaging, there’s a risk the PRP ends up in the wrong spot, which could reduce its effectiveness.

For cosmetic applications like hair restoration, the approach is different. PRP is typically injected across the scalp in a grid pattern using fine needles, sometimes combined with microneedling. The goal is to distribute the growth factors evenly across the treatment area rather than targeting a single lesion.

What Pain Feels Like and How It’s Managed

Pain during a PRP injection ranges from mild to moderate, depending on the injection site and the individual. Joint injections tend to cause a pressure sensation and brief sharp sting. Tendon injections, which go into tissue that’s already inflamed, can be more uncomfortable. Scalp injections are generally the most tolerable.

Local anesthetics can help, but not all of them play nicely with PRP. Research comparing common local anesthetics found that bupivacaine was harmful to platelets, increasing cell death and reducing their ability to stick together. By contrast, lidocaine and ropivacaine were relatively safe and could be mixed with PRP at reasonable dilutions without destroying its therapeutic potential.⁶ If your clinician offers numbing before a PRP injection, it’s worth asking which anesthetic they use. Lidocaine is the most common safe choice.

After the injection, expect some soreness at the site for a few days. This is partly from the needle itself and partly from the inflammatory response that PRP is designed to trigger. Ice and acetaminophen are commonly recommended for short-term discomfort, though the relationship between pain medication and PRP effectiveness is something to discuss with your provider, as described below.

Medications You Should Pause

One of the most practical things to know before a PRP injection is which medications to stop, and for how long. A systematic review found that aspirin, acetaminophen, and nonselective anti-inflammatory drugs like ibuprofen and naproxen should be considered for suspension before PRP treatment because they can diminish the injection’s effects.⁷ These drugs interfere with platelet activation, which is the very mechanism PRP relies on.

The post-injection period matters too. Anti-inflammatory drugs can suppress growth factors in PRP and potentially interfere with the healing cascade for weeks after the shot. Research suggests a one-week washout period after stopping anti-inflammatories may be enough for key growth factor levels in PRP to return to normal, but the tissue-repair process that PRP kicks off continues for weeks. Most clinical trials that restricted anti-inflammatory use after injection did so for more than a month.⁸ This is a real inconvenience for people who rely on anti-inflammatories for daily pain management, and it’s a conversation to have with your doctor well before the procedure date.

PRP for Knee Osteoarthritis

The strongest body of evidence for PRP injections sits in knee osteoarthritis, where multiple meta-analyses have found meaningful benefits. A large meta-analysis of randomized controlled trials found that PRP produced statistically superior improvements in both pain and function scores compared with placebo at all follow-up points, and the improvements exceeded the threshold for what patients would consider a clinically meaningful difference.⁹

PRP has also been compared head-to-head with hyaluronic acid, a gel-like substance commonly injected into arthritic knees. A systematic review found that patients treated with PRP had significantly better functional scores than those who received hyaluronic acid, both at three to six months and at six to twelve months.¹⁰ Another meta-analysis confirmed this, showing PRP was significantly better at reducing pain than both placebo and hyaluronic acid at six months.¹¹

Despite this evidence, clinical practice guidelines from around the world have been cautious. A review of international guidelines found that while hyaluronic acid and corticosteroid injections had numerous formal recommendations in their favor, guidelines for PRP were more uncertain, with most unable to definitively recommend for or against its use based on the evidence available at the time.¹² The gap between what the trial data shows and what guidelines recommend has been closing, but it remains a source of frustration for both patients and providers.

PRP for Tendon Problems

Lateral epicondylitis, commonly called tennis elbow, is one of the conditions with the best evidence for PRP. A multicenter randomized trial of 230 patients found that those treated with PRP had significantly greater pain improvement than controls at 24 weeks, with about a 72 percent improvement in pain scores compared to 56 percent in the control group. Success rates at 24 weeks were roughly 84 percent for PRP versus 68 percent for the control treatment.¹³ An earlier study found that benefits kept building over time, with PRP-treated patients reporting a 93 percent reduction in pain at an average of about two years after treatment.¹⁴

A clinical review supported these findings broadly, noting strong evidence for PRP in lateral epicondylitis and moderate evidence for patellar tendinopathy and plantar fasciitis. The same review, however, found that current evidence shows a lack of efficacy for PRP in Achilles tendinopathy, muscle injuries, and acute fractures.¹⁵ This is an important nuance. PRP is not a blanket solution for every musculoskeletal injury; it works better for some conditions than others, and the tendon matters.

PRP Versus Cortisone Shots

Many patients considering PRP are weighing it against corticosteroid injections, which have been a go-to for decades. The comparison plays out differently depending on the timeline. For rotator cuff problems, one meta-analysis found that corticosteroids provided better short-term relief in the first several weeks, but by the midterm there was no significant difference, and in the long term PRP actually produced better functional outcomes.¹⁶ Another meta-analysis looking at the same comparison found results slightly favoring PRP at three to six weeks for pain, but no meaningful difference by 12 or 24 weeks.¹⁷

For tennis elbow, a randomized trial with two-year follow-up told a clearer story. The PRP group was significantly more often successfully treated than the corticosteroid group at two years. While both groups initially improved, the corticosteroid group’s function scores drifted back toward their pre-treatment baseline, while the PRP group’s scores continued to improve.¹⁸ This pattern, cortisone winning in the short term but fading while PRP holds or improves, appears across several conditions and is probably the most useful thing to understand when choosing between the two. If you need quick relief for an event or deadline, cortisone delivers faster. If you’re managing a chronic condition and thinking long term, PRP may be the smarter bet.

Hair Loss and Aesthetic Applications

PRP has become popular in dermatology, particularly for androgenetic alopecia (pattern hair loss). The approach typically involves injecting PRP across the scalp at regular intervals, often combined with microneedling, which creates tiny punctures that may enhance PRP absorption. A study of 60 patients found that about two-thirds of those who completed four PRP sessions achieved good to excellent results, and the researchers concluded that a minimum of four sessions was needed for meaningful improvement.¹⁹

Combining PRP with other treatments appears to boost results. A systematic review found that patients treated with a combination of minoxidil, PRP, and microneedling reported the highest satisfaction compared with minoxidil alone, and the combination increased hair growth more than either PRP with minoxidil or either treatment as monotherapy.²⁰ A split-scalp study comparing microneedling alone to microneedling plus PRP found both approaches improved hair density, with the PRP side showing slightly higher gains, though the difference between the two sides did not reach statistical significance.²¹ The evidence here is positive but more modest than in knee osteoarthritis, and maintenance sessions are usually needed to sustain results.

Safety and Side Effects

Because PRP is made from your own blood, the risk of allergic reaction or disease transmission is essentially zero. The main safety concerns are those shared by any injection: pain at the site, temporary swelling, and a small chance of infection. A large meta-analysis comparing the safety of common knee injections found that PRP had the lowest rate of adverse events per treated patient among the options studied: the average number of total adverse events per patient was 0.05 for PRP, compared to 0.13 for hyaluronic acid, 0.21 for corticosteroids, and 0.19 for cell-based therapies. Severe adverse events occurred in only about 0.3 percent of PRP patients.²²

A broader literature survey of adverse events across all PRP applications identified postoperative infection as the most commonly reported problem, along with rarer events like inflammation, nodule formation, and, in facial injection contexts, isolated cases of blindness from inadvertent vascular injection.²³ These severe complications are rare but underscore the importance of having PRP performed by experienced clinicians, especially for facial injections where blood vessel anatomy is complex.

Who Shouldn’t Get PRP

PRP is not appropriate for everyone, and a 2025 international consensus laid out detailed guidance on who should proceed with caution and who should wait. The general principle is that active infections and active cancers are the clearest reasons to hold off. PRP should not be injected near tumors, whether benign or malignant, and patients with solid cancers considered active by their oncologist should not receive PRP except in exceptional circumstances. Patients with blood cancers that are not yet stabilized fall under the same restriction.²⁴

The guidelines are more permissive than many patients expect in other situations. People with controlled HIV (undetectable viral load, adequate immune cell counts) can receive PRP. Patients on long-term immunosuppressive therapy can proceed as long as there’s no concurrent infection. Those with a cancer history that their oncologist considers cured are cleared. Even moderately low platelet counts above 50,000 per cubic millimeter are not a contraindication, as long as the cause has been investigated and blood cancers have been ruled out.²⁴ Dental infections are a surprisingly specific exclusion: PRP should wait until dental treatment is complete and healing has occurred. The logic is that active oral infections can seed bacteria into the bloodstream, creating a risk of contaminating the injection site.

Why Results Vary Between Patients

One of the most honest things a clinician can tell you is that PRP works differently for different people, and the reasons go beyond just the condition being treated. Research has shown significant variation in growth factor levels between individual patients’ PRP samples, influenced by age and baseline platelet counts.²⁵ In other words, the quality of the raw material varies from person to person.

Age, sex, body weight, and disease severity all appear to influence outcomes. Expert position statements have noted that younger patients with less advanced disease and lower body mass index tend to report better results from PRP. Studies have also found that male patients tend to have higher levels of both inflammatory and anti-inflammatory signaling molecules in their PRP compared with female patients, which could affect how the healing process unfolds.²⁶ None of this means PRP won’t work for older patients or those with more advanced conditions, but expectations should be calibrated accordingly.

The placebo question also hovers over PRP research. In a randomized trial for hip osteoarthritis, even the group that received saline injections (the placebo arm) showed significant improvements in some quality-of-life measures at one and six months.²⁷ A study of chronic Achilles tendinopathy found that pain and function scores improved across all groups, including sham treatment.²⁸ For conditions where PRP does clearly beat placebo, like knee osteoarthritis, this is less of a concern. For conditions where the evidence is weaker, the placebo effect is harder to separate from genuine biological benefit.

Leukocyte-Rich Versus Leukocyte-Poor Formulations

Not all PRP is the same product. One of the main distinctions in the field is between leukocyte-rich PRP, which retains white blood cells in the concentrate, and leukocyte-poor PRP, which filters most of them out. The debate over which is better has persisted for years and remains unresolved.²⁹ The general thinking is that leukocyte-rich preparations may trigger a stronger initial inflammatory response, which could be beneficial for tendon healing but counterproductive inside a joint that’s already inflamed. Clinical recommendations have reflected this split: leukocyte-rich PRP has been recommended for lateral epicondylitis, while leukocyte-poor PRP has been preferred for knee osteoarthritis.¹⁵

This distinction matters practically because many clinics use a single commercial preparation kit for all conditions. If you’re getting PRP for a knee and the clinic’s kit produces a leukocyte-rich product, or vice versa, it’s worth asking whether the formulation matches the evidence for your specific condition. Many patients never think to ask this question, and frankly, not all providers consider it either.

Cost and the Regulatory Landscape

PRP sits in an unusual regulatory space in the United States. It is not FDA-approved for specific medical indications, but it can legally be offered off-label because the preparation uses a patient’s own blood processed with FDA-cleared devices. A single treatment typically costs between $500 and $2,500, and most insurance plans do not cover it. Since many conditions require multiple injections, the total cost can add up quickly.³⁰

The researchers who documented these costs emphasized that because clearance of the preparation device is not the same as approval of the therapy for a specific condition, patients should be informed that they are receiving an off-label treatment. This is especially relevant given that clinical trial results, while promising for certain indications like knee osteoarthritis and tennis elbow, are not yet definitive across the board. If a provider presents PRP as a proven cure-all with guaranteed results, that’s a red flag. The honest pitch is that PRP has solid evidence for some uses, promising but incomplete evidence for others, and known limitations that include biological variability, formulation differences, and ongoing debates about optimal protocols.

PRP Beyond Joints and Hair

While orthopedic and aesthetic uses get the most attention, PRP is also being studied in wound care, particularly for chronic wounds that resist conventional treatment. In patients with diabetic foot ulcers, PRP injected around wound edges and into the ulcer base was effective in promoting healing in about 80 percent of cases, compared to roughly 46 percent with conventional dressing alone.³¹ Chronic wounds are a massive clinical problem, especially for people with diabetes, and PRP’s ability to deliver concentrated healing signals directly to stalled wound beds makes it a logical candidate for this use. The application here is the same basic idea as in a tendon or joint: draw blood, spin it, inject the concentrate where it’s needed, and let the growth factors do their work. The needle may change, the target tissue may change, but the underlying principle is consistent across applications.